A comparative study between 2% Sertaconazole vs topical 1% Butenafine in tinea infections of ski
Phase 4
Completed
- Conditions
- Health Condition 1: null- Tinea infections of skin
- Registration Number
- CTRI/2012/06/002714
- Lead Sponsor
- Department of Pharmacology and Department of Skin and VD CU Shah Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 125
Inclusion Criteria
New cases of tinea infections of skin from skin OPD
Exclusion Criteria
1) Follow up cases
2) Pregnant and Lactating women
3) patients having hypersensitivity to one of the antifungal agents used in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method a) Efficacy( 1. Change in baseline sign and symptom score 2. Change in Physicians Global Evaluation Response b). Safety (No. Of patients developing ADRs and type of ADRs) c). Cost effectivenes (Incremental cost and Incremental effectiveness)Timepoint: a) Efficacy( 1. Change in baseline sign and symptom score 2. Change in Physicians Global Evaluation Response b). Safety (No. Of patients developing ADRs and type of ADRs) c). Cost effectivenes (Incremental cost and Incremental effectiveness)
- Secondary Outcome Measures
Name Time Method 1) Clinicomycological correlation <br/ ><br>2)Relapse rate asssessment <br/ ><br>3)Find out the prevalent species of tinea infectionsTimepoint: one month